RESEARCH-USE BIOSIMILAR ANTIBODY
Tovetumab
Monoclonal antibody · IgG2
Tovetumab (MEDI-575) is an anti-PDGFRα monoclonal antibody that selectively blocks the PDGFRα signal transduction. Tovetumab can be used in the research of glioblastoma and non-small cell lung cancer (NSCLC).
TARGETPDGFRA
YMonoclonal antibody
CATALOGSC-BS-098
CATALOG NUMBERSC-BS-098
MOLECULAR WEIGHTApprox. 145.39 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Tovetumab (MEDI-575) is an anti-PDGFRα monoclonal antibody that selectively blocks the PDGFRα signal transduction. Tovetumab can be used in the research of glioblastoma and non-small cell lung cancer (NSCLC).
Tovetumab is a recombinant research-use antibody directed against PDGFRA.